SEVERE WX : Winter Weather Advisory View Alerts
STREAMING NOW: Watch Now

FDA approves new drug for migraine sufferers

The US Food and Drug Administration on Monday...

Posted: Dec 24, 2019 9:45 AM

The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.

The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers.

"Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication," Dr. Billy Dunn, acting director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said in a statement Monday.

In a study published last month, the drug showed greater rates of pain and symptom relief from migraine compared to a placebo, with more than 19% of participants given the drug reporting to be pain-free within two hours and nearly 40% relieved of the most bothersome symptoms linked to migraine, which include light and noise sensitivity. This is compared to roughly 12% and 28%, respectively, from the placebo. Nausea, sleepiness and dry mouth were the most commonly reported side effects.

Some migraines can be treated with over-the-counter medications such as ibuprofen, acetaminophen or aspirin, if taken at the first signs of a migraine occurring. When these aren't effective, the most commonly prescribed treatment is a class of drugs called triptans, which are considered more effective than ubrogepant but have a catch: They work by constricting blood vessels around the brain to stop the pain, so they are not considered safe for use by people at risk of cardiovascular disease and stroke. The newly approved drug, on the other hand, has a different molecular target -- a protein involved in the transmission of pain.

An estimated 40 million Americans and 1 billion people worldwide suffer from migraines. The condition affects one in five women and one in 16 men, according to the American Migraine Foundation.

New York Coronavirus Cases

County data is updated nightly.

Cases: 1980337

Reported Deaths: 51418
CountyCasesDeaths
Kings2621119933
Queens2613019549
Suffolk1920063307
Nassau1759193106
Bronx1735626372
New York1307874308
Westchester1248812238
Erie811411694
Richmond700891744
Monroe603251034
Orange45755782
Rockland45439941
Onondaga35694661
Dutchess27720433
Albany23473343
Oneida21329497
Niagara17999332
Broome17239348
Saratoga14292160
Ulster12882241
Schenectady12332192
Rensselaer10567136
Putnam1011391
Chautauqua8304132
Chemung7081133
Oswego693990
Ontario681191
Steuben6231141
St. Lawrence615594
Sullivan606168
Cayuga582590
Jefferson542463
Wayne519667
Cattaraugus509880
Genesee5028121
Herkimer4896107
Clinton450132
Madison427385
Tompkins403449
Fulton402186
Livingston397058
Montgomery3861115
Columbia380999
Cortland352260
Tioga335758
Warren334956
Wyoming322651
Otsego315646
Allegany315483
Greene309474
Chenango304874
Washington282655
Orleans273483
Lewis243233
Franklin238312
Delaware213736
Seneca185756
Schoharie153815
Essex149326
Yates110126
Schuyler98313
Hamilton3012
Unassigned172100
Out of NY0216
Rome
Cloudy
38° wxIcon
Hi: 47° Lo: 36°
Feels Like: 38°
Binghamton
Cloudy
33° wxIcon
Hi: 45° Lo: 33°
Feels Like: 29°
Rome
Cloudy
38° wxIcon
Hi: 48° Lo: 37°
Feels Like: 38°
Rome
Cloudy
38° wxIcon
Hi: 44° Lo: 33°
Feels Like: 38°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
Saluting Those Who Are Proud 2 Serve
Enter the Rock Your Body Giveaway from Alivana Aesthetics
Looking for work or looking to hire? Check out the WKTV Job Fair!